New search | Conferencedetail
Print view

Hemophilia Drug Development

evvnt Platform / evvnt
Conference themes
Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapy, the inaugural Hemophilia Drug Development Summit plays host to the leading pharma and biotech players working to develop longer acting and more efficacious therapies to overcome significant unmet medical need and prevent resistance to factor replacement therapies.
Professional congress organizer (PCO)
Hanson Wade



Speakers: Daniel Leonard, Director of Global Patient Advocacy, UniQure, Craig Benson, Clinical Research Director

Enquiries and Registration:
Mr. Charlotte Harrison
General Medicine, Health Services
Congress fees
USD 2.398,00
(Conference + 2 Workshops: USD 2398.0, Conference + 1 Workshop: USD 1949.0, Conference Only: USD 1499.0)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Charité International AcademyEuropean Health Forum GasteinÄrzte der WeltAnästhesie in Entwicklungsländern e. V.European Public Health Association (EUPHA)Helix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthAMREF - African Medical and Research Foundation


Give us your professional opinion

Start survey

Start survey